Oncology Database

Selected news for Oncology Database, representing 92% of data collected since 11/2017. Recent stories appear in hematologyadvisor.com and malvern-online.com. We are still establishing shared news links for this healthcare topic.

Please provide a valid email address.
Shares Healthcare News With (link):
Healthcare Topics

Selected Headines

Date Headline (link) Source Relevant Snippet
10/22/2020 Modern Radiation Therapy Limits Radiation Doses to Organs at Risk in Hodgkin Lymphoma hematologyadvisor.com ... to determine the radiation doses delivered to organs at risk with consolidative modern involved-site RT in patients with ESFHL treated with 20 Gy after 2 cycles of ABVD.The investigators screened the radiation oncology database maintained by the University of Texas MD Anderson Cancer Center for medical records of adult patients with ESFHL (German Hodgkin Study Group criteria) who had been treated with combined modality therapy from 2010 to ...
9/17/2020 malvern-online.com ... the Emmes SARS-CoV-2 Testing Database. This database serves as the latest addition to the market intelligence products already under DeciBio Consulting’s umbrella. Such products include the Emmes Infectious Disease Database, the Emmes Oncology Database , BioMAP (immuno-oncology biomarkers), Marketbooks, Dexter, and BioTrack, among others. The DeciBio Emmes SARS-CoV-2 Testing Database provides data visualization tools and raw data covering coronavirus testing practices in approximately 400 labs in ...
4/17/2020 Optimizing the Analytical Value of Oncology-Related Data Based on an In-Memory Analysis Layer: Development and Assessment of the Munich Online Comprehensive Cancer Analysis Platform jmir.org ... patients themselves, their medical history, and tumor descriptives. The software is suitable for not only a specific tumor site but also for all solid and nonsolid tumors, resulting in a large, complex, and comprehensive oncology database . The software was established at the local sites in 2010 and now includes most tumor entities. By the end of 2018, the databases contained detailed information for more than 20,000 patients at each site ...
9/20/2019 DeciBio Consulting Acquires Emmes Group's Molecular Diagnostic (MDx) Testing & Oncology Databases Benzinga DeciBio Consulting, LLC, a precision medicine-focused strategy consulting and market intelligence firm, is pleased to announce it has acquired ownership of the Emmes Molecular Diagnostics (MDx) Infectious Disease Database and the Oncology Database from The Emmes Group Inc., effective January 1, 2020. These acquisitions are positioned to strengthen and expand the solutions DeciBio offers its clients. The Emmes MDx (ID) Database has established itself as a unique and essential ...
9/20/2019 DeciBio Consulting Acquires Emmes Group’s Molecular Diagnostic (MDx) Testing & Oncology Databases truckingnews.us ... WIRE)– infectiousdisease –DeciBio Consulting, LLC, a precision medicine-focused strategy consulting and market intelligence firm, is pleased to announce it has acquired ownership of the Emmes Molecular Diagnostics (MDx) Infectious Disease Database and the Oncology Database from The Emmes Group Inc., effective January 1, 2020. These acquisitions are positioned to strengthen and expand the solutions DeciBio offers its clients. The Emmes MDx (ID) Database has established itself as a unique ...
9/20/2019 DeciBio Consulting Acquires Emmes Group’s Molecular Diagnostic (MDx) Testing & Oncology Databases sys-con.com Blog This DeciBio Consulting, LLC, a precision medicine-focused strategy consulting and market intelligence firm, is pleased to announce it has acquired ownership of the Emmes Molecular Diagnostics (MDx) Infectious Disease Database and the Oncology Database from The Emmes Group Inc., effective January 1, 2020. These acquisitions are positioned to strengthen and expand the solutions DeciBio offers its clients. The Emmes MDx (ID) Database has established itself as a unique ...
9/20/2019 DeciBio Consulting Acquires Emmes Group’s Molecular Diagnostic (MDx) Testing & Oncology Databases BioSpace ... BUSINESS WIRE )-- DeciBio Consulting, LLC, a precision medicine-focused strategy consulting and market intelligence firm, is pleased to announce it has acquired ownership of the Emmes Molecular Diagnostics (MDx) Infectious Disease Database and the Oncology Database from The Emmes Group Inc., effective January 1, 2020. These acquisitions are positioned to strengthen and expand the solutions DeciBio offers its clients. The Emmes MDx (ID) Database has established itself as a unique ...
9/19/2019 DeciBio Consulting Acquires Emmes Group’s Molecular Diagnostic (MDx) Testing & Oncology Databases | Business & Finance | manchestertimes.com Business Wire LOS ANGELES--(BUSINESS WIRE)--Sep 19, 2019-- DeciBio Consulting, LLC, a precision medicine-focused strategy consulting and market intelligence firm, is pleased to announce it has acquired ownership of the Emmes Molecular Diagnostics (MDx) Infectious Disease Database and the Oncology Database from The Emmes Group Inc., effective January 1, 2020. These acquisitions are positioned to strengthen and expand the solutions DeciBio offers its clients. The Emmes MDx (ID) Database has ...
9/19/2019 DeciBio Consulting Acquires Emmes Group’s Molecular Diagnostic (MDx) Testing & Oncology Databases malvern-online.com DeciBio Consulting, LLC, a precision medicine-focused strategy consulting and market intelligence firm, is pleased to announce it has acquired ownership of the Emmes Molecular Diagnostics (MDx) Infectious Disease Database and the Oncology Database from The Emmes Group Inc., effective January 1, 2020. These acquisitions are positioned to strengthen and expand the solutions DeciBio offers its clients. The Emmes MDx (ID) Database has established itself as a unique and essential ...
9/19/2019 DeciBio Consulting Acquires Emmes Group’s Molecular Diagnostic (MDx) Testing & Oncology Databases wapakdailynews.com DeciBio Consulting, LLC, a precision medicine-focused strategy consulting and market intelligence firm, is pleased to announce it has acquired ownership of the Emmes Molecular Diagnostics (MDx) Infectious Disease Database and the Oncology Database from The Emmes Group Inc., effective January 1, 2020. These acquisitions are positioned to strengthen and expand the solutions DeciBio offers its clients. The Emmes MDx (ID) Database has established itself as a unique and essential ...
4/10/2019 Natera Announces Plans to Commercialize Tumor Whole Exome Sequencing from Plasma PR Newswire ... including the ability to design Signatera™ assays when tissue is not available. The assay may also allow researchers to characterize resistance mutations, actionable mutations, neoantigens, and tumor evolution. Finally, this capability will enhance Natera's oncology database by generating valuable new data about tumor evolution over time. The plasma exome service can be ordered as a stand-alone assay, or reflexively for Signatera ctDNA-positive cases. Many researchers want a comprehensive ...